In tandem with its $100 million IPO, the biopharma-focused SPAC said it has an agreement with sponsor Jiya Holding Company for the sponsor to buy 500,000 shares of Class A common stock at $10 per share, resulting in proceeds of $5 million. Read more.
Related Posts
Magnum Opus Wins Extension, Loses Nearly 2/3rds of Trust Value on Redemptions
Redemptions totaling approximately $137 million left about $67.5 million in the Magnum Opus trust ahead of the extension vote, according to the filing.
Chain Bridge I Asks Shareholders for 9 More Months
Fulton AC I earlier this month bought the original sponsor's shares and warrants, and took over management of the SPAC. Potential merger targests have since been identified and discussions have begun, according to the proxy.
Health Assurance Files Definitive Prospectus on $500M IPO
The SPAC offers what it calls 50,000,000 SAIL (Stakeholder Aligned Initial Listing) Securities that trade on the Nasdaq under the symbol “HAACU.”
Climate Real Impact Solutions II Prices $210M IPO
Climate Real Impact is focused on companies engaged in carbon reduction initiatives that address global warming.